Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy

Neuropathology and Applied Neurobiology

Volumn 27, Issue 3, 2001, Pages 223-237

  Aronica, Eleonora ^a,b,e   Yankaya, Bulent ^a   Jansen, Gerard H ^c   Leenstra, Sieger ^a   Van Veelen, Cees W M ^c   Gorter, Jan A ^b,d   Troost, Dirk ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Brain tumours; Dysembryoplastic neuroepithelial tumours; Epilepsy; Gangliogliomas; Glutamate receptors; Immunocytochemistry; Perilesional reactive astrocytes

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; BRAIN TUMOR; CELL POPULATION; CHILD; EPILEPTOGENESIS; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; NEUROEPITHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; EPILEPSY; FEMALE; GANGLIOGLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, NEUROEPITHELIAL; RECEPTORS, GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; TERATOMA;

EID: 0034911570     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2001.00314.x     Document Type: Article

References (89)

1. Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats
2. Activation of metabotropic glutamate receptors delays apoptosis of chick embryonic motor neurons in vitro
3. Non-plaque dystrophic dendrites in Alzheimer hippocampus: A new pathological structure revealed by glutamate receptor immunocytochemistry
4. Expression of connexin 43 and connexin 32 gap junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex
5. Glioneuronal tumors and intractable epilepsy: A clinical study with long-term follow-up of seizure outcome after surgery
6. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy
7. Status epilepticus-induced alterations in metabotropic glutamate receptor expression in young and adult rats
8. Expression of BDNF and Tyrosine kinase B (TrkB) receptor proteins in glioneuronal tumors from patients with intractable epilepsy: Colocalization with NMDA receptor
9. Glia and neurons in dialogue
10. Glial ion channels
11. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus
12. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia
13. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: Correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients
14. Metabotropic glutamate receptor activation contributes to nociceptive reflex activity in the rat spinal cord in vitro
15. Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element
16. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-β
17. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): Comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors
18. Metabotropic glutamate receptor activation decreases epileptiform activity in rat neocortex
19. Glutamate receptors in epilepsy
20. Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture
21. Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas
22. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide
23. Modulation of seizure activity in mice by metabotropic glutamate receptor ligands
24. Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus
25. Laminar segregation of the cortical plate during corticogenesis is accompanied by changes in glutamate receptor expression
26. Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes
27. The high-affinity glutamate transporters GLT1, GLAST and EAAT4 are regulated via different signalling mechanisms
28. Immunohistochemical localization of Group I and II metabotropic glutamate receptors in control and ALS human spinal cord: Upregulation in reactive astrocytes
29. Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil
30. The molecular neuron-glia couple and epileptogenesis
31. Intraoperative optical imaging of epileptiform and functional activity
32. Contribution of astrocytes to seizure activity
33. Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors
34. Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition
35. Localization of non-N-methyl-D-aspartate glutamate receptors in normal and Alzheimer hippocampal formation
36. Pathology of temporal lobectomy for refractory seizures in children. Review of 20 cases including some unique malformative lesions
37. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: A light and electron microscopic study
38. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system
39. Glutamate receptor activation can trigger electrical activity in human glioma cells
40. The early reactions of non-neuronal cells to brain injury
41. Human epileptic astrocytes exhibit increased gap junction coupling
42. Price DLAMPA glutamate receptor subunits are differentially distributed in rat brain
43. Hippocampal AMPA and NMDA mRNA levels and subunit immuno-reactivity in human temporal lobe epilepsy patients and a rodent model of chronic mesial limbic epilepsy
44. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs
45. Glutamate receptors and transporters in genetic and acquired models of epilepsy
46. Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro
47. NMDA-receptors I and 2A/B coassembly increased in human epileptic focal cortical dysplasia
48. Roles of metabotropic glutamate receptors in brain plasticity and pathology
49. Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5
50. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
51. Light and electron microscopic distribution of the AMPA receptor subunit. GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice
52. Molecular diversity of glutamate receptors and implications for brain function
53. Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro
54. Immunohistochemical expression of trk receptor proteins in focal cortical dysplasia with intractable epilepsy
55. Astrocyte responses to CNS injury
56. Presynaptic localization of a metabotropic glutamate receptor, mGluR7, in the primary afferent neurons: An immunohistochemical study in the rat
57. Glutamate-mediated astrocyte-neuron signalling
58. Neuronlike physiological properties of cells from human oligodendroglial tumors
59. The GluR2 (GluR-B) hypothesis: Ca (2 +)-permeable AMPA receptors in neurological disorders
60. Immunocytochemistry of NMDA receptors
61. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody
62. Composite ganglioglioma and dysembryoplastic neuroepithelial tumor
63. Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: A study of 60 patients with intracranial tumors
64. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus
65. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture
66. Pharmacological agents acting at subtypes of metabotropic glutamate receptors
67. Assembly-disassembly of metabotropic glutamate receptor 3 and water channel aquaporin 4 in astrocyte cell membrane
68. Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus
69. Sulcogyral variation in NMDA receptor 2A/B subunit immunoreactivity in human brain
70. Glutamate opens Na+/K+ channels in cultured astrocytes
71. News on glutamate receptors in glial cells
72. Hyperexcitability associated with localizable lesions in epileptic patients
73. Lipton SANMDA receptors: From genes to channels
74. Glial uptake of excitatory amino acids influences neuronal survival in cultures of mouse hippocampus
75. Role of metabotropic glutamate receptors in the hypersusceptibility to pentylenetetrazole-induced seizure during diazepam withdrawal
76. Neuroendocrine markers in central nervous system neuronal tumors (gangliocytoma and ganglioglioma)
77. Neurofilament proteins and human nervous system tumors
78. Structural determinants of ion flow through recombinant glutamate receptor channels
79. Glial calcium: Homeostasis and signaling function
80. Quantitative localization of AMPA/kainate and kainate glutamate receptor subunit immunoreactivity in neurochemically identified subpopulations of neurons in the prefrontal cortex of the macaque monkey
81. Synaptic distribution of the AMPA-GluR2 subunit and its co-localization with calcium-binding proteins in rat cerebral cortex: An immunohistochemical study using a GluR2-specific monoclonal antibody
82. Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication
83. Novel glial-neuronal signalling by coactivation of metabotropic glutamate and β-adrenergic receptors in rat hippocampus
84. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies
85. Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors
86. Malformative and neoplastic glioneuronal lesions in patients with chronic pharmacoresistant epilepsies
87. Role of metabotropic glutamate receptors in epilepsy
88. Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex